HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jade Peres Selected Research

Breast Neoplasms (Breast Cancer)

1/2018Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jade Peres Research Topics

Disease

12Neoplasms (Cancer)
01/2021 - 03/2010
7Melanoma (Melanoma, Malignant)
01/2023 - 03/2010
2Neoplasm Metastasis (Metastasis)
01/2023 - 01/2018
2Esophageal Squamous Cell Carcinoma
01/2018 - 01/2018
2Ulnar-mammary syndrome
07/2017 - 01/2015
1Disease Progression
01/2021
1Rhabdomyosarcoma
02/2020
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Alcoholism (Alcohol Abuse)
01/2018

Drug/Important Bio-Agent (IBA)

8Transcription Factors (Transcription Factor)IBA
02/2020 - 03/2010
3Transcription Factor 3IBA
01/2023 - 07/2017
3Cadherins (E-Cadherin)IBA
01/2021 - 01/2015
3Proteins (Proteins, Gene)FDA Link
02/2020 - 03/2010
2Metformin (Glucophage)FDA LinkGeneric
01/2018 - 01/2018
1CollagenIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021
1AgarIBA
02/2020
1TubulinIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
1Disulfiram (Antabuse)FDA Link
01/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2018
1NucleotidesIBA
01/2018
1GemcitabineFDA Link
01/2018
1Fluorouracil (Carac)FDA LinkGeneric
01/2018
1Messenger RNA (mRNA)IBA
10/2017
13' Untranslated Regions (3' UTR)IBA
10/2017
1Cell Adhesion MoleculesIBA
01/2015
1RNA (Ribonucleic Acid)IBA
03/2010

Therapy/Procedure

5Therapeutics
01/2021 - 01/2015
1Drug Therapy (Chemotherapy)
01/2018